Multicentral study for evaluating hepatic steatosis using Ultrasound-guided attenuation parameter (UGAP) by comparison with MRI-determined proton density fat fraction (PDFF)
Not Applicable
Completed
- Conditions
- Chronic liver disease
- Registration Number
- JPRN-UMIN000041196
- Lead Sponsor
- Ogaki Municipal Hospital
- Brief Summary
GAP has excellent diagnostic accuracy for grading steatosis with reference to MRI-PDFF. Additionally, UGAP has good linearity and negligible bias, suggesting that UGAP has excellent technical performance characteristics that can be widely used in clinical trials and patient care. (UMIN Clinical Trials Registry, Number: UMIN000041196).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1010
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients without claustrophobia 2.Patients without magnetic substance or tattoo 3.Patients without pacemakers 4.Patients judged as inappropriate for the study by the study responsibility (share) physician.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We assess the accuracy of UGAP in assessing hepatic steatosis compared to PDFF
- Secondary Outcome Measures
Name Time Method We verify whether UGAP can diagnose fatty liver (liver fat content 5% or more)